vs

Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and US ENERGY CORP (USEG). Click either name above to swap in a different company.

US ENERGY CORP is the larger business by last-quarter revenue ($1.7M vs $1.1M, roughly 1.5× Insight Molecular Diagnostics Inc.). US ENERGY CORP runs the higher net margin — -192.2% vs -2015.4%, a 1823.1% gap on every dollar of revenue. On growth, Insight Molecular Diagnostics Inc. posted the faster year-over-year revenue change (-23.4% vs -64.9%). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs -51.3%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

NextEra Energy, Inc. is an American energy company that is the world's largest electric utility holding company by market capitalization, with a valuation of over $170 billion as of Oct 2024. NextEra Energy had revenues of $24.8 billion and 16,700 employees throughout the US and Canada in 2024. It has a current generating capacity of 73 gigawatts. Its subsidiaries include Florida Power & Light (FPL), NextEra Energy Resources (NEER), XPLR Energy Partners, and NextEra Energy Services.

IMDX vs USEG — Head-to-Head

Bigger by revenue
USEG
USEG
1.5× larger
USEG
$1.7M
$1.1M
IMDX
Growing faster (revenue YoY)
IMDX
IMDX
+41.6% gap
IMDX
-23.4%
-64.9%
USEG
Higher net margin
USEG
USEG
1823.1% more per $
USEG
-192.2%
-2015.4%
IMDX
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
-51.3%
USEG

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IMDX
IMDX
USEG
USEG
Revenue
$1.1M
$1.7M
Net Profit
$-23.0M
$-3.3M
Gross Margin
42.5%
Operating Margin
-2057.5%
-194.4%
Net Margin
-2015.4%
-192.2%
Revenue YoY
-23.4%
-64.9%
Net Profit YoY
31.5%
-48.7%
EPS (diluted)
$-0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMDX
IMDX
USEG
USEG
Q4 25
$1.1M
Q3 25
$260.0K
$1.7M
Q2 25
$518.0K
$2.0M
Q1 25
$2.1M
$2.2M
Q4 24
$1.5M
$4.2M
Q3 24
$115.0K
$5.0M
Q2 24
$104.0K
$6.0M
Q1 24
$176.0K
$5.4M
Net Profit
IMDX
IMDX
USEG
USEG
Q4 25
$-23.0M
Q3 25
$-10.9M
$-3.3M
Q2 25
$-9.7M
$-6.1M
Q1 25
$-6.7M
$-3.1M
Q4 24
$-33.5M
Q3 24
$-13.5M
$-2.2M
Q2 24
$-4.5M
$-2.0M
Q1 24
$-9.1M
$-9.5M
Gross Margin
IMDX
IMDX
USEG
USEG
Q4 25
42.5%
Q3 25
53.5%
Q2 25
67.6%
Q1 25
62.0%
Q4 24
40.0%
Q3 24
43.5%
Q2 24
48.1%
Q1 24
25.6%
Operating Margin
IMDX
IMDX
USEG
USEG
Q4 25
-2057.5%
Q3 25
-4249.2%
-194.4%
Q2 25
-1900.0%
-307.6%
Q1 25
-318.0%
-140.8%
Q4 24
-2262.9%
-278.9%
Q3 24
-11752.2%
-83.8%
Q2 24
-4453.8%
-28.4%
Q1 24
-5265.3%
-148.8%
Net Margin
IMDX
IMDX
USEG
USEG
Q4 25
-2015.4%
Q3 25
-4174.6%
-192.2%
Q2 25
-1880.7%
-298.7%
Q1 25
-312.0%
-141.9%
Q4 24
-2255.1%
Q3 24
-11733.0%
-45.3%
Q2 24
-4355.8%
-32.6%
Q1 24
-5186.9%
-176.9%
EPS (diluted)
IMDX
IMDX
USEG
USEG
Q4 25
$-0.75
Q3 25
$-0.34
Q2 25
$-0.30
$-0.19
Q1 25
$-0.26
Q4 24
$-2.19
$-0.42
Q3 24
$-0.98
$-0.08
Q2 24
$-0.36
$-0.08
Q1 24
$-1.13
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMDX
IMDX
USEG
USEG
Cash + ST InvestmentsLiquidity on hand
$11.6M
$1.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-31.5M
$25.0M
Total Assets
$25.8M
$46.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMDX
IMDX
USEG
USEG
Q4 25
$11.6M
Q3 25
$18.7M
$1.7M
Q2 25
$24.3M
$6.9M
Q1 25
$31.0M
$10.6M
Q4 24
$8.6M
$7.9M
Q3 24
$3.4M
$1.3M
Q2 24
$9.3M
$2.4M
Q1 24
$5.6M
$2.2M
Stockholders' Equity
IMDX
IMDX
USEG
USEG
Q4 25
$-31.5M
Q3 25
$-9.2M
$25.0M
Q2 25
$1.1M
$28.0M
Q1 25
$10.2M
$33.6M
Q4 24
$-12.3M
$24.2M
Q3 24
$9.7M
$35.7M
Q2 24
$22.7M
$37.7M
Q1 24
$11.6M
$36.7M
Total Assets
IMDX
IMDX
USEG
USEG
Q4 25
$25.8M
Q3 25
$43.9M
$46.5M
Q2 25
$50.5M
$51.0M
Q1 25
$60.4M
$55.8M
Q4 24
$35.1M
$49.7M
Q3 24
$70.2M
$64.1M
Q2 24
$74.7M
$73.7M
Q1 24
$71.0M
$70.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMDX
IMDX
USEG
USEG
Operating Cash FlowLast quarter
$-5.5M
$-155.0K
Free Cash FlowOCF − Capex
$-7.0M
FCF MarginFCF / Revenue
-616.7%
Capex IntensityCapex / Revenue
129.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMDX
IMDX
USEG
USEG
Q4 25
$-5.5M
Q3 25
$-4.5M
$-155.0K
Q2 25
$-6.3M
$-1.6M
Q1 25
$-5.9M
$-4.5M
Q4 24
$-5.4M
$1.7M
Q3 24
$-5.5M
$2.6M
Q2 24
$-6.0M
$929.0K
Q1 24
$-3.8M
$-603.0K
Free Cash Flow
IMDX
IMDX
USEG
USEG
Q4 25
$-7.0M
Q3 25
$-5.6M
Q2 25
$-6.6M
Q1 25
$-6.2M
Q4 24
$-5.6M
Q3 24
$-5.6M
Q2 24
$-6.2M
Q1 24
$-3.9M
FCF Margin
IMDX
IMDX
USEG
USEG
Q4 25
-616.7%
Q3 25
-2135.4%
Q2 25
-1279.5%
Q1 25
-288.4%
Q4 24
-374.5%
Q3 24
-4884.3%
Q2 24
-5931.7%
Q1 24
-2189.8%
Capex Intensity
IMDX
IMDX
USEG
USEG
Q4 25
129.9%
Q3 25
403.8%
Q2 25
67.4%
Q1 25
14.4%
Q4 24
14.4%
Q3 24
75.7%
Q2 24
183.7%
Q1 24
13.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMDX
IMDX

Segment breakdown not available.

USEG
USEG

Oil Sales$1.6M91%
Other$151.0K9%

Related Comparisons